Q1 2018 13F Holders as of 31 Mar 2018
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
165,565,585
-
Share change
-
+18,974,507
-
Total reported value
-
$8,665,636,727
-
Put/Call ratio
-
142%
-
Price per share
-
$52.34
-
Number of holders
-
279
-
Value change
-
+$990,377,878
-
Number of buys
-
143
-
Number of sells
-
109
Institutional Holders of SEATTLE GENETICS INC - COM (SGEN) as of Q1 2018
As of 31 Mar 2018,
SEATTLE GENETICS INC - COM (SGEN) was held by
279 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
165,565,585 shares.
The largest 10 holders included
BAKER BROS. ADVISORS LP, BAILLIE GIFFORD & CO, PRIMECAP MANAGEMENT CO/CA/, WELLINGTON MANAGEMENT GROUP LLP, PRICE T ROWE ASSOCIATES INC /MD/, VANGUARD GROUP INC, BlackRock Inc., Capital International Investors, FMR LLC, and Matrix Capital Management Company, LP.
This page lists
279
institutional shareholders reporting positions in this security
for the Q1 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.